This task exploits results obtained in the first two tasks and translates knowledge on existing pharmacological interventions to generate new candidate drugs in close involvement of small to medium sized enterprises.
Candidate small molecules and molecule libraries will be tested in a successive developmental platform. This will lead to patent filing, licensing strategies and to phase I and II clinical trials.
TOP OF SITE
PRINT
